Submitted by Anonymous (not verified) on 17 October 2023 - 16:38
Human medicines European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis), pemetrexed, Carcinoma, Non-Small-Cell Lung;Mesothelioma, Date of authorisation: 18/01/2016, Revision: 14, Status: Authorised
Source: